This Article Abstract Full Text (PDF) All Versions of this Article: 35/1/94    most recent 01.STR.0000106136.15163.73v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thijs, V. N. Articles by Albers, G. W. Search for Related Content PubMed PubMed Citation Articles by Thijs, V. N. Articles by Albers, G. W.

(Stroke. 2004;35:94.)
© 2004 American Heart Association, Inc.

Original Contributions

Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging

Vincent N. Thijs, MD; Diederik M. Somford, MD; Roland Bammer, PhD; Wim Robberecht, MD, PhD; Michael E. Moseley, PhD Gregory W. Albers, MD

From the Department of Neurology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Belgium (V.N.T., W.R.), and Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif (V.N.T., D.M.S., R.B., M.E., G.W.A.).

Correspondence to Vincent Thijs, Department of Neurology, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. E-mail vincent.thijs{at}uz.kuleuven.ac.be

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background and Purpose— The arterial input function (AIF) is critical in determining hemodynamic parameters quantitatively with bolus-tracking MRI. We studied the effect of varying the location of measurement of AIF on the volume of hypoperfusion. We compared the volumes of hypoperfusion obtained with different AIFs with the final ischemic lesion volume.

Methods— We included 13 patients with acute cerebral ischemia in the anterior circulation who underwent diffusion- (DWI) and perfusion (PWI)-weighted imaging within 8 hours after symptom onset and exhibited DWI lesion expansion between baseline and follow-up. AIF was measured at 4 locations: near both middle cerebral arteries (MCAs), in MCA branches adjacent to the largest DWI abnormality, and at the same level on the opposite hemisphere. Hypoperfusion lesion volumes were compared with the DWI volume at follow-up.

Results— Large variations in PWI lesion size were found with different AIF locations. The largest PWI lesions were found when AIF was measured at the contralateral MCA. Smaller PWI lesions were found when AIF was measured in the other locations. There was no significant difference between PWI lesion area at baseline and follow-up DWI lesion when AIF was measured at the contralateral MCA. The other PWI lesions significantly underestimated follow-up DWI lesion size.

Conclusions— AIF is an important determinant of the size of hypoperfusion lesions measured with PWI. PWI lesion volumes determined with AIF from the contralateral MCA are associated with follow-up lesion volume.

Key Words: magnetic resonance imaging, diffusion-weighted • magnetic resonance imaging, perfusion-weighted • stroke, acute • stroke, ischemic

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Dynamic susceptibility contract-enhanced MRI is increasingly used to measure cerebral hemodynamic parameters in acute stroke patients.¹ In combination with diffusion-weighted imaging (DWI), perfusion-weighted imaging (PWI) provides a powerful tool to identify tissue that might be rescued by acute intervention.² Several shortcomings have been identified with the quantification of the dynamic susceptibility contract-enhanced MRI technique,^3,4 including problems with measurement of the arterial input function (AIF) and with identification of tissue characteristics like hematocrit and brain density that are required to measure cerebral blood flow (CBF) accurately.

The function describing the concentration of gadolinium contrast agent over time as it enters the brain, called the AIF, is critical in determining hemodynamic parameters quantitatively with bolus-tracking MRI.^1,5 The ideal location to determine AIF remains controversial.³ Partial volume artifacts might bias the results of AIF measurements in small vessels.⁶ On the other hand, AIF should be measured as close as possible to the tissue of interest to minimize delay and dispersion of the bolus between the area of measurement and the tissue of interest.⁷ It is also unclear whether AIF should be measured in the hemisphere ipsilateral to or opposite the hypoperfusion lesion.

We studied the effect of varying the location of measurement of AIF on the obtained volume of hypoperfusion. We compared the volumes of hypoperfusion obtained with different AIFs with the final DWI lesion volume and assessed whether AIF could be measured reliably by different observers.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Patients
We identified patients with acute nonlacunar ischemic stroke entered into the Stanford Stroke Center Database in whom an MRI with DWI and PWI was obtained within 8 hours of symptom onset and 4 to 7 days after symptom onset. This later period was chosen because previous studies indicate that DWI lesion volume growth is complete by 4 to 7 days.⁸ Eligible patients were required to have an acute DWI lesion volume that increased in volume between baseline and follow-up to identify patients who had tissue at risk of infarction at baseline. Treatment with recombinant tissue plasminogen activator or enrollment in trials of neuroprotective agents versus placebo was allowed. The following clinical characteristics were recorded: age, National Institutes of Health Stroke Scale (NIHSS) score, time from symptom onset to MR, and Trial of Org 10172 in Acute Stroke Treatment (TOAST) subtype.⁹ The study was approved by the Stanford Institutional Review Board.

Imaging and Postprocessing
MRI
MRI was performed with echo planar imaging on a 1.5-T General Electric Signa magnet. Multislice whole-brain DWI was performed with the following parameters: slices, 16; repetition time, 8100 ms; echo time, 110 ms; slice thickness, 5 mm; gap, 2.5 mm; matrix, 128x128; and field of view, 24 cm. The b values were 0 and 829 s/mm². DWI scans were acquired with diffusion encoding along the x, y, or z direction. The x-, y-, and z-direction DWI scans were averaged to minimize hyperintensities resulting from anisotropic water diffusion.

PWI was performed with dynamic susceptibility contrast-enhanced MRI. Gradient echo, single-shot echo planar imaging was used during injection of gadolinium (0.2 mmol/kg). PWI acquisition values were as follows: repetition time, 2000 ms; and echo time, 60 ms, obtained over 12 slices (40 time points each). Other parameters were the same as for DWI. The 12 PWI slices were taken at the same level as the 12 central slices on the DWI scans.

Postprocessing of Perfusion Images
The bolus-tracking raw images were realigned with automated image registration.¹⁰ PWI maps were calculated with the truncated singular value decomposition method described by Ostergaard et al^11,12 using previously described software.¹³ The tissue concentration over time curve was deconvolved with AIF using the truncated singular value decomposition method to obtain the residue function. The residue function is the amount of tracer that remains in the voxel of interest over time after an idealized, instantaneous bolus of contrast. No analytical fit of AIF was performed. AIF was measured at 4 locations: near the contralateral and ipsilateral middle cerebral arteries in the M1 and M2 segments (AIF_CMCA and AIF_IMCA), in middle cerebral artery (MCA) branches adjacent to the largest diffusion abnormality (AIF_IDWI), and at the same level on the opposite hemisphere (AIF_CDWI). The pixels chosen to determine AIF had to show an early rise of intensity and a large increase in intensity on the tissue concentration–time curve compared with normal brain parenchyma. Although no formal quantitative criterion was used to determine AIF, quantitative information regarding the onset of the intensity increase and the area under the curve (AUC) was continuously available when AIF was selected. The AUC of the AIF was measured by integrating the relaxivity-over-time curve (Figure 1) This AUC measurement is biased because no method was used to eliminate recirculation. An unbiased AUC is required to determine CBF, cerebral blood volume, and mean transit time accurately. However, an accurate determination of the AUC is not required for determining the Tmax parameter used in our study. Tmax is a hemodynamic parameter that estimates the delay of the peak of the tissue residue function obtained by deconvolution.¹³ Tmax allows rapid visual identification of areas with varying degrees of hypoperfusion.

View larger version (23K): [in this window] [in a new window]   Figure 1. Relaxivity (R*) vs time for AIF obtained from contralateral MCA (A), ipsilateral MCA (B), MCA branches in the contralateral hemisphere at the level of diffusion abnormality (C), and MCA branches in the vicinity of the DWI abnormality (D). AUCs for these AIFs were 822, 688, 663, and 571, respectively. R* was determined as the negative log of susceptibility after baseline normalization (in arbitrary units).

Lesion volume measurements on DWI and PWI images were performed by a semiautomated method using a threshold function. The threshold for defining a pathological DWI hyperintensity was chosen as 3 SD above the mean normal DWI signal intensity determined from a reference region containing both white and gray matter in the contralateral hemisphere. PWI abnormalities were defined as the areas of hypoperfusion with a Tmax delay of 2 seconds. This threshold was chosen because visual analysis of Tmax >1 second showed this threshold to be overly sensitive. Tmax lesions of >6 and 8 seconds were recently shown to have a high likelihood of subsequent infarction.¹⁴ A PWI-DWI mismatch was defined as a baseline hypoperfusion lesion volume that was 120% the volume of the baseline diffusion lesion volume.

Interobserver Reliability
Two independent observers (V.T., D.S.) independently measured AIF to assess interobserver reliability in a subset of 10 randomly chosen patients. The volumes obtained with the AIF at the different locations by each observer were compared, and the intraclass correlation coefficients were measured for each location.

Statistical Analysis
The AUCs of AIFs obtained at different locations were compared by use of Friedman’s test. Pairwise comparisons were then performed by use of Wilcoxon’s paired rank-sum test to determine significant differences among AIFs at different locations. Hypoperfusion lesion volumes with AIFs obtained from different locations were compared with the follow-up DWI lesion volume through paired t tests. Regression analysis was used to identify the hypoperfusion lesion volume that was most closely associated with the DWI lesion volume at follow-up. All statistical tests were 2 tailed, and a value of P=0.05 was considered significant. All statistical tests were performed with SPSS 10.0.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Patients
We identified 30 patients who underwent DWI and PWI within 8 hours of symptom onset between August 1, 1996, and August 1, 2000. In 4 patients, poor image quality resulting from motion artifact or inadequate bolus delivery prevented analysis of the perfusion images. Three patients did not have repeated imaging within 4 to 7 days after symptom onset. Ten patients did not have lesion growth between baseline and follow-up. This left 13 patients for analysis. The median age was 69 years (range, 43 to 88 years), and 7 (54%) were female. The median baseline NIHSS was 13 (range, 6 to 23; the Table). The etiologic classification of strokes was cardioembolic in 7 patients (54%), large-vessel disease in 2 (15%), and cryptogenic in 4 patients (31%). One of the cryptogenic patients had an ipsilateral high-grade carotid stenosis and atrial fibrillation. A high-grade carotid stenosis ipsilateral to the cerebral ischemia was therefore present in 3 patients in total.

View this table: [in this window] [in a new window]   Clinical and Volumetric Lesion Data

The time between baseline and MRI was a median of 5:15 hours (25th percentile, 4:03; 75th percentile, 6:40). The median baseline DWI volume was 28 cm³ (25th percentile, 22.4; 75th percentile, 84.4). One patient did not have a baseline DWI lesion. Follow-up images were obtained a median of 5.1 days (range, 4 to 6.4 days) after symptom onset. Lesion volumes increased a median of 227% (25th percentile, 147%; 75th percentile, 279%) between baseline and follow-up.

Nine patients were enrolled in trials of neuroprotective agents versus placebo (cervene, n=5; lubeluzole, n=4).¹⁵ One patient received tissue plasminogen activator and was enrolled in a neuroprotective agent trial (lubeluzole).¹⁶ One patient was treated with tissue plasminogen activator according to the National Institute of Neurological Disorders and Stroke criteria.¹⁷ Patients treated with thrombolytics were imaged with MRI as soon after treatment as possible.

Interobserver Reliability
The intraclass correlation coefficients for measurement of the volumes of hypoperfusion using AIFs from different locations were 0.89 with AIF_CDWI and 0.87 with AIF_IDWI. The intraclass correlation coefficient was 0.93 with AIF_CMCA and 0.88 with AIF_IMCA.

AIF Characteristics
The AUCs of AIFs obtained at different locations were significantly different (P<0.0001). The AUC of AIF_CMCA (median, 937; interquartile range [IQR], 672 to 1036) was significantly larger than the AUC of AIF_IDWI (median, 413; IQR, 278 to 529; P=0.001) and AIF_CDWI (median, 588; IQR, 377 to 723; P=0.003). The AUC of AIF_CMCA tended to be larger than the AUC from AIF_IMCA (median, 764; IQR, 598 to 930; P=0.08). The AUC of AIF_IMCA was significantly larger than the AUC of AIF_IDWI (P=0.001) and tended to be larger than that of AIF_CDWI (P=0.055). The last AUC was larger than the AUC of AIF_IDWI (P=0.039).

Volume Characteristics
Large variations in PWI lesion size were found with different AIF locations (the Table). The largest PWI lesions were found when AIF was measured at the contralateral MCA. These PWI lesions were significantly larger than the PWI lesions obtained with AIF_IMCA (mean difference, 60 mL; P=0.0022), AIF_CDWI (mean difference, 37.3 cm³; P=0.0054), and AIF_IDWI (mean difference, 77.8; P=0.0001). The volumes obtained with AIF_CMCA spatially enclosed the volumes identified with other AIFs. The volumes obtained with AIF_IMCA, AIF_CDWI, and AIF_IDWI significantly underestimated the final lesion volume. There was no significant difference between the volumes obtained with AIF_CMCA at baseline and the final lesion volume (mean difference, 12.16 cm³; 95% confidence interval, -40.8 to 16; P=0.37). Regression analysis showed that this PWI lesion was associated with final lesion volume (R=0.6, P=0.002; Figure 2). These differences remained significant after exclusion of the 3 patients with ipsilateral high-grade carotid artery stenosis.

View larger version (22K): [in this window] [in a new window]   Figure 2. Correlations between baseline PWI lesion volume obtained with different AIFs and DWI lesion volume at days 4 to 7. Continuous line represents fitted curve obtained by regression analysis between these 2 variables.

The PWI/DWI mismatch frequency was 100% (13 of 13) with AIF_CMCA, 77% (10 of 13) with AIF_CDWI, 38.5% (5 of 13) with AIF_IMCA, and 23% (3 of 13) with AIF_IDWI. Figure 3 shows baseline PWI maps of a patient scanned 6.8 hours after symptom onset with an NIHSS of 13.

View larger version (122K): [in this window] [in a new window]   Figure 3. Baseline PWI maps of patient 10 scanned 6.8 hours after symptom onset with an NIHSS of 13. PWI determined from AIFIDWI (A), AIFIMCA (B), AIFCDWI (C), and AIFCMCA (D). E, DWI lesion at follow-up. PWI maps shown are an overlay of pixels with Tmax 2 seconds on the baseline T2*-gradient echo slice. The majority of pixels within this lesion have Tmax 4 seconds.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
Our study shows that AIF is an important determinant of the size of hypoperfusion lesion as measured with Tmax. PWI lesion volumes determined with AIF from the contralateral MCA were associated with follow-up lesion volumes, whereas volumes obtained with other AIFs overestimated or underestimated follow-up DWI lesion volumes. Our study suggests that the optimal location to determine AIF is in the M1 or M2 segment of the MCA in the hemisphere opposite the hypoperfusion lesion.

To include patients who had tissue at risk of infarction at baseline, we studied only patients who exhibited lesion growth between baseline and follow-up. Several patients had a mismatch (PWI>DWI) when AIF was measured in 1 location and did not exhibit a mismatch with another AIF. To determine the optimal location for measurement of the AIF, we did not include patients on the basis of the presence or absence of a mismatch because this would create a bias favoring 1 location over another.

The AIF with the largest AUC was AIF_CMCA, followed by AIF_ICMA, AIF_CDWI, and AIF_IDWI. The differences between the ipsilateral and contralateral AUCs of the AIF are related to the difficulty of choosing pixels that are not affected by hypoperfusion on the ipsilateral side of the ischemic lesion without knowing a priori the extent of hypoperfusion. The differences between AIF from the MCA stem and from smaller MCA branches are probably due to the caliber variation between these vessels and larger partial volume effects within smaller vessels.

A few studies have examined the relationship between AIF location and the size and severity of perfusion abnormalities. Ostergaard et al¹² found similar shapes of AIF when measured at different brain locations, but no volumetric data were provided. Lythgoe et al¹⁸ compared the CBF values in gray matter generated by the use of AIFs from either the contralateral or the ipsilateral MCA in patients with carotid stenosis or occlusion. CBF estimations were different between the ipsilateral and contralateral arteries, and those authors suggested using the contralateral MCA in patients with high-grade carotid stenosis. A recent study, however, found no difference in CBF values in patients with carotid occlusion when AIF was obtained ipsilateral or contralateral to the stenosis or occlusion in 6 of 7 patients. In 1 patient, a significant difference was found.¹⁹ Another study in normal subjects found significant differences in AIF shape between the MCA and the internal carotid and vertebral arteries.²⁰

This study has several limitations. The sample size was small; therefore, these findings need to be reproduced in a larger sample of patients. Several patients were treated with intravenous tissue plasminogen activator or with putative neuroprotective agents. In these patients, the amount of lesion growth between baseline and follow-up might have been different without treatment. Vasogenic edema might also have contributed to the volume increases between the 2 time points. We included 3 patients with high-grade carotid artery stenosis ipsilateral to the ischemic lesion. The volume of hypoperfusion might be exaggerated in these patients.²¹ However, exclusion of these patients in our sample did not significantly change our findings.

PWI has not been validated against the gold standard of PET in patients with acute ischemic stroke. Several other shortcomings of this technique have been highlighted recently. These include bias introduced by bolus delay and dispersion, assumptions about tissue hematocrit, and biased measurement of AIF by partial volume effects.^3,6 Tmax is less commonly used as a perfusion parameter.^13,14 Future studies should examine the relationship between Tmax and other hemodynamic parameters and determine whether AIF location also influences the volumes of these PWI lesions.

In conclusion, we found that AIF is a major determinant of the size of hypoperfusion lesions obtained with PWI. PWI lesion volumes determined with AIF from the contralateral MCA are associated with the follow-up lesion volume and might be used in conjunction with DWI to identify tissue at risk of infarction.

	Acknowledgments

 
Dr Thijs is supported by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen. This study was supported in part by NIH grants NS-34088–03, R01 NS35959, and R01 NS34866–06.

Received April 30, 2003; revision received September 2, 2003; accepted September 8, 2003.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999; 19: 701–735.[CrossRef][Medline] [Order article via Infotrieve]
2. Albers GW. Expanding the window for thrombolytic therapy in acute stroke: the potential role of acute MRI for patient selection. Stroke. 1999; 30: 2230–2237.[Abstract/Free Full Text]
3. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke. 2002; 33: 1146–1151.[Abstract/Free Full Text]
4. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metab. 1984; 4: 633–634.[Medline] [Order article via Infotrieve]
5. Perthen JE, Calamante F, Gadian DG, et al. Is quantification of bolus tracking MRI reliable without deconvolution? Magn Reson Med. 2002; 47: 61–67.[CrossRef][Medline] [Order article via Infotrieve]
6. van Osch MJ, Vonken EJ, Bakker CJ, et al. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med. 2001; 45: 477–485.[CrossRef][Medline] [Order article via Infotrieve]
7. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med. 2000; 44: 466–473.[CrossRef][Medline] [Order article via Infotrieve]
8. Lansberg MG, O’Brien MW, Tong DC, et al. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol. 2001; 58: 613–617.[Abstract/Free Full Text]
9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35–41.[Abstract/Free Full Text]
10. Woods RP, Grafton ST, Holmes CJ, et al. Automated image registration, I: general methods and intrasubject, intramodality validation. J Comput Assist Tomogr. 1998; 22: 139–152.[CrossRef][Medline] [Order article via Infotrieve]
11. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part I: mathematical approach and statistical analysis. Magn Reson Med. 1996; 36: 715–725.[Medline] [Order article via Infotrieve]
12. Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part II: experimental comparison and preliminary results. Magn Reson Med. 1996; 36: 726–736.[Medline] [Order article via Infotrieve]
13. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47: 462–469.[CrossRef][Medline] [Order article via Infotrieve]
14. Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke. 2003; 34: 1425–1430.[Abstract/Free Full Text]
15. Clark WM, Raps EC, Tong DC, et al. Cervene (nalmefene) in acute ischemic stroke: final results of a phase III efficacy study: the Cervene Stroke Study Investigators. Stroke. 2000; 31: 1234–1239.[Abstract/Free Full Text]
16. Grotta J. the US and Canadian Lubeluzole Ischemic Stroke Study Group. Lubeluzole treatment of acute ischemic stroke: Stroke. 1997; 28: 2338–2346.[Abstract/Free Full Text]
17. the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke: N Engl J Med. 1995; 333: 1581–1587.[Abstract/Free Full Text]
18. Lythgoe DJ, Ostergaard L, William SC, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000; 18: 1–11.[CrossRef][Medline] [Order article via Infotrieve]
19. Mukherjee P, Kang HC, Videen TO, et al. Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. AJNR Am J Neuroradiol. 2003; 24: 862–871.[Abstract/Free Full Text]
20. Rausch M, Scheffler K, Rudin M, et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn Reson Imaging. 2000; 18: 1235–1243.[CrossRef][Medline] [Order article via Infotrieve]
21. Neumann-Haefelin T, Wittsack HJ, Fink GR, et al. Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. Stroke. 2000; 31: 1311–1317.[Abstract/Free Full Text]

This article has been cited by other articles:

				I. Kane, T. Carpenter, F. Chappell, C. Rivers, P. Armitage, P. Sandercock, and J. Wardlaw Comparison of 10 Different Magnetic Resonance Perfusion Imaging Processing Methods in Acute Ischemic Stroke: Effect on Lesion Size, Proportion of Patients With Diffusion/Perfusion Mismatch, Clinical Scores, and Radiologic Outcomes Stroke, December 1, 2007; 38(12): 3158 - 3164. [Abstract] [Full Text] [PDF]

				M. G. Lansberg, V. N. Thijs, S. Hamilton, G. Schlaug, R. Bammer, S. Kemp, G. W. Albers, and on behalf of the DEFUSE Investigators Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE Stroke, June 1, 2007; 38(6): 1826 - 1830. [Abstract] [Full Text] [PDF]

				I Kane, P Sandercock, and J Wardlaw Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 485 - 491. [Abstract] [Full Text] [PDF]

				MR Stroke Collaborative Group Proof-of-Principle Phase II MRI Studies in Stroke: Sample Size Estimates From Dichotomous and Continuous Data Stroke, October 1, 2006; 37(10): 2521 - 2525. [Abstract] [Full Text] [PDF]

				K W Muir, H M Halbert, T A Baird, M McCormick, and E Teasdale Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 334 - 339. [Abstract] [Full Text] [PDF]

				M. Mlynash, I. Eyngorn, R. Bammer, M. Moseley, and D. C. Tong Automated Method for Generating the Arterial Input Function on Perfusion-Weighted MR Imaging: Validation in Patients with Stroke AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1479 - 1486. [Abstract] [Full Text] [PDF]

				J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, V. Hesselmann, M. Neveling, A. Jacobs, and W.-D. Heiss Does the Mismatch Match the Penumbra?: Magnetic Resonance Imaging and Positron Emission Tomography in Early Ischemic Stroke Stroke, May 1, 2005; 36(5): 980 - 985. [Abstract] [Full Text] [PDF]

				J.-C. Baron and S. Warach Imaging Stroke, February 1, 2005; 36(2): 196 - 199. [Full Text] [PDF]

				J. Sobesky, O. Z. Weber, F.-G. Lehnhardt, V. Hesselmann, A. Thiel, C. Dohmen, A. Jacobs, M. Neveling, and W.-D. Heiss Which Time-to-Peak Threshold Best Identifies Penumbral Flow?: A Comparison of Perfusion-Weighted Magnetic Resonance Imaging and Positron Emission Tomography in Acute Ischemic Stroke Stroke, December 1, 2004; 35(12): 2843 - 2847. [Abstract] [Full Text] [PDF]

				S. E. Rose, A. L. Janke, M. Griffin, S. Finnigan, and J. B. Chalk Improved Prediction of Final Infarct Volume Using Bolus Delay-Corrected Perfusion-Weighted MRI: Implications for the Ischemic Penumbra Stroke, November 1, 2004; 35(11): 2466 - 2471. [Abstract] [Full Text] [PDF]

				W.-D. Heiss, J. Sobesky, and V. Hesselmann Identifying Thresholds for Penumbra and Irreversible Tissue Damage Stroke, November 1, 2004; 35(11_suppl_1): 2671 - 2674. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 35/1/94    most recent 01.STR.0000106136.15163.73v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thijs, V. N. Articles by Albers, G. W. Search for Related Content PubMed PubMed Citation Articles by Thijs, V. N. Articles by Albers, G. W.